The Valley Desk

ReviewCancersPublished

Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Cancers
Published
Subject terms
Melanoma; Immunotherapy; Biomarker; Predictive Factor; Immune Checkpoint Inhibitors
PubMed ID
38201531
PubMed Central ID
PMC10778365
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal